Sectors
CRDL
Cardiol Therapeutics Inc.
1.98
2 x 1.38
2 x 2.43
bid
ask
+
0.04
1.80%
2 @ 07:30 PM
1.95 -0.03 (1.27%)
| Ytd | 107.02% | |
| 1y | 82.87% |
1.88
day range
1.98
0.88
52 week range
2.27
| Open | 1.92 | Prev Close | 1.94 | Low | 1.88 | High | 1.98 | Mkt Cap | 230.72M |
| Vol | 780.88K | Avg Vol | 928.58K | EPS | -0.25 | P/E | N/A | Forward P/E | -4.03 |
| Beta | 0.70 | Short Ratio | 1.37 | Inst. Own | 9.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.35 | 200-d Avg | 1.18 | 1yr Est | 8.70 |
| Income Statement | |||
| Operating Expenses | 7.94M | ||
| Research and Development Expense | 3.20M | ||
| Selling, General and Administrative Expense | 4.74M | ||
| Operating Income | -7.94M | ||
| Net Income | -6.08M | ||
| Net Income Common Stock | -6.08M | ||
| Net Income Common Stock (USD) | -4.28M | ||
| Consolidated Income | -6.08M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -6.08M | ||
| Earning Before Interest & Taxes (USD) | -4.28M | ||
| Weighted Average Shares | 114.94M | ||
| Weighted Average Shares Diluted | 114.94M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.08M | ||
| Cash and Equivalents (USD) | 18.37M | ||
| Trade and Non-Trade Receivables | 312.61K | ||
| Current Assets | 29.23M | ||
| Property, Plant & Equipment Net | 130.45K | ||
| Total Assets | 29.36M | ||
| Debt Current | 41.31K | ||
| Total Debt | 107.00K | ||
| Current Liabilities | 5.26M | ||
| Debt Non-Current | 65.69K | ||
| Total Liabilities | 5.33M | ||
| Accumulated Retained Earnings (Deficit) | -229.97M | ||
| Shareholders Equity | 24.03M | ||
| Shareholders Equity (USD) | 16.92M | ||
| Assets Non-Current | 130.45K | ||
| Total Debt (USD) | 75.35K | ||
| Liabilities Non-Current | 65.69K | ||
| Trade and Non-Trade Payables | 3.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 11.55K | ||
| Net Cash Flow from Financing | 2.48M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.91M | ||
| Capital Expenditure | -3.03K | ||
| Issuance (Purchase) of Equity Shares | 2.49M | ||
| Issuance (Repayment) of Debt Securities | -13.84K | ||
| Net Cash Flow from Investing | -3.03K | ||
| Net Cash Flow from Operations | -4.38M | ||
| Effect of Exchange Rate Changes on Cash | 313.11K | ||
| Share Based Compensation | 2.38M | ||